Table 2. Changes in metabolic and plasma measures from fasting to the post-prandial state in both the Placebo and RSV conditions.
| Placebo | RSV | |||
| Fasted | Post-prandial | Fasted | Post-prandial | |
| VO2 (ml/min) ‡ | 307±108 | 340±97 | 373±111 | 387±124 |
| RER | 0.82±0.05 | 0.81±0.05 | 0.81±0.06 | 0.82±0.07 |
| Fatty Acid Oxidation (kcal/min) | 0.87±0.15 | 1.04±0.22 | 0.97±0.19 | 1.11±0.18 |
| Plasma Glycerol (mmol/L) ‡ | 0.08±0.02 | 0.07±0.03 | 0.10±0.03 | 0.08±0.04 |
| Plasma Insulin (µIU/L) † ‡ | 7.2±3.5 | 27.6±5.7 | 7.8±3.3 | 19.0±2.5 |
| Plasma Glucose (mmol/L) | 5.1±0.2 | 5.2±0.2 | 5.3±0.3 | 5.0±0.3 |
Values are means ± SD. VO2, Oxygen uptake; RER, Respiratory Exchange Ratio; ml, millimeters; kcal, kilocalories; mmol, millimole; mIU, micro international units.
‡
Significant effect (P<0.05) of time.
†
Significant interaction (P<0.05).